GVBLBiotechnology
Genomic Valley Biotech Ltd — Profit & Loss Statement
₹28.00
+3.74%
Genomic Valley Biotech Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -2476.71 | 0.11 Cr | — |
| Tax Rate For Calcs | 0.19 | 0.30 | 0.00 | 0.30 | — |
| Normalized EBITDA | 0.44 Cr | 0.02 Cr | 0.92 Cr | -0.24 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | -0.26 Cr | 0.37 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -0.26 Cr | 0.37 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 0.36 Cr | 0.02 Cr | 0.65 Cr | -93402.00 | — |
| Reconciled Depreciation | 25414.00 | 10925.00 | 79243.00 | 0.08 Cr | — |
| Reconciled Cost Of Revenue | 0.20 Cr | 0.00 | 1.58 Cr | 19410.00 | — |
| EBITDA | 0.44 Cr | 0.02 Cr | 0.66 Cr | 0.13 Cr | — |
| EBIT | 0.44 Cr | 0.02 Cr | 0.65 Cr | 0.04 Cr | — |
| Net Interest Income | 0.00 | 0.00 | 0.04 Cr | 0.04 Cr | — |
| Interest Expense | 0.00 | 0.00 | 2397.00 | 0.04 Cr | — |
| Normalized Income | 0.36 Cr | 0.02 Cr | 0.91 Cr | -0.27 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.36 Cr | 0.02 Cr | 0.65 Cr | -93402.00 | — |
| Total Expenses | 0.41 Cr | 0.15 Cr | 1.85 Cr | 0.47 Cr | — |
| Diluted Average Shares | 0.30 Cr | 0.30 Cr | 0.31 Cr | 0.31 Cr | — |
| Basic Average Shares | 0.30 Cr | 0.30 Cr | 0.31 Cr | 0.31 Cr | — |
| Diluted EPS | 1.17 | 0.05 | 2.12 | -0.03 | — |
| Basic EPS | 1.17 | 0.05 | 2.12 | -0.03 | — |
| Diluted NI Availto Com Stockholders | 0.36 Cr | 0.02 Cr | 0.65 Cr | -93402.00 | — |
| Net Income Common Stockholders | 0.36 Cr | 0.02 Cr | 0.65 Cr | -93402.00 | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.36 Cr | 0.02 Cr | 0.65 Cr | -93402.00 | — |
| Net Income Including Noncontrolling Interests | 0.36 Cr | 0.02 Cr | 0.65 Cr | -93402.00 | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 0.36 Cr | 0.02 Cr | 0.65 Cr | -93402.00 | — |
| Tax Provision | 0.09 Cr | -339.00 | 6080.00 | 76910.00 | — |
| Pretax Income | 0.44 Cr | 0.02 Cr | 0.65 Cr | -16492.00 | — |
| Other Non Operating Income Expenses | 44660.00 | 15003.00 | 0.04 Cr | 0.08 Cr | — |
| Special Income Charges | 0.00 | 0.00 | -0.26 Cr | 0.37 Cr | — |
| Net Non Operating Interest Income Expense | 0.00 | 0.00 | 0.04 Cr | 0.04 Cr | — |
| Interest Expense Non Operating | 0.00 | 0.00 | 2397.00 | 0.04 Cr | — |
| Operating Income | 0.44 Cr | 0.01 Cr | 0.87 Cr | -0.40 Cr | — |
| Operating Expense | 0.21 Cr | 0.15 Cr | 0.27 Cr | 0.47 Cr | — |
| Other Operating Expenses | 0.08 Cr | 0.11 Cr | 0.08 Cr | 0.18 Cr | — |
| Depreciation And Amortization In Income Statement | 25414.00 | 10925.00 | 79243.00 | 0.08 Cr | — |
| Depreciation Income Statement | 25414.00 | 10925.00 | 79243.00 | 0.08 Cr | — |
| Gross Profit | 0.64 Cr | 0.17 Cr | 1.14 Cr | 0.07 Cr | — |
| Cost Of Revenue | 0.20 Cr | 0.00 | 1.58 Cr | 19410.00 | — |
| Total Revenue | 0.84 Cr | 0.17 Cr | 2.72 Cr | 0.07 Cr | — |
| Operating Revenue | 0.84 Cr | 0.17 Cr | 2.72 Cr | 0.07 Cr | — |
| Interest Income | — | 0.00 | 0.04 Cr | 0.08 Cr | 151.00 |
| Other Special Charges | — | -15000.00 | 0.26 Cr | -0.42 Cr | — |
| Write Off | — | 21972.00 | 0.00 | 0.05 Cr | 0.02 Cr |
| Total Other Finance Cost | — | 1694.00 | 26531.00 | 2475.00 | 5579.00 |
| Interest Income Non Operating | — | 0.00 | 0.04 Cr | 0.08 Cr | 151.00 |
| Selling General And Administration | — | 0.05 Cr | 0.02 Cr | 95720.00 | 0.01 Cr |
| Selling And Marketing Expense | — | 42840.00 | 41400.00 | 41720.00 | 48910.00 |
| General And Administrative Expense | — | 0.05 Cr | 0.01 Cr | 54000.00 | 76214.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Genomic Valley Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.